AI maps brain cancer recurrence to guide surgeons in removing more tumor
NCT ID NCT05735171
Summary
This pilot study tested whether using artificial intelligence (AI) maps to guide brain surgery could help patients with glioblastoma live longer. The AI was trained to predict where the aggressive brain tumor was most likely to regrow based on MRI scans. Surgeons used these maps to try to safely remove more of the tumor tissue beyond the main mass in 20 selected patients, aiming to delay recurrence and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Rio Hortega
Valladolid, Valladolid, 47012, Spain
Conditions
Explore the condition pages connected to this study.